| P2093 | author name string | F-C Lin | |
| | A S Wolberg | |
| | B L Walton | |
| | W Bergmeier | |
| | S Uitte de Willige | |
| | T M Getz | |
| P2860 | cites work | The kinetics of αIIbβ3 activation determines the size and stability of thrombi in mice: implications for antiplatelet therapy | Q30498119 |
| | Plasma gamma'/gamma fibrinogen ratio, a marker of arterial thrombotic activity: a new potential cardiovascular risk factor? | Q33539778 |
| | Gamma' fibrinogen: evaluation of a new assay for study of associations with cardiovascular disease | Q34552336 |
| | Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice | Q35001664 |
| | Pathophysiologic roles of the fibrinogen gamma chain | Q35838102 |
| | I-fibrinogen as an oncophilic radiodiagnostic agent: distribution kinetics in tumour-bearing mice | Q36069244 |
| | Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). | Q36404689 |
| | The presence of gamma' chain impairs fibrin polymerization | Q37363845 |
| | Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability | Q37450566 |
| | Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains | Q42194253 |
| | Differential regulation of fibrinogen γ chain splice isoforms by interleukin-6. | Q42218786 |
| | Inhibition of thrombin-mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ'. | Q44001534 |
| | Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men. | Q46146417 |
| | Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway | Q46970925 |
| | Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential | Q47228596 |
| | Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen | Q47293932 |
| | Hypofibrinolysis is a risk factor for arterial thrombosis at young age. | Q48774215 |
| | Association of gammaA/gamma' fibrinogen levels and coronary artery disease. | Q50277146 |
| | Fibrinogen and risk of cardiovascular disease. The Framingham Study. | Q52588834 |
| | Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness. | Q52623827 |
| | Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. | Q52860374 |
| | Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. | Q52993523 |
| | Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. | Q53909571 |
| | Characterization of the Murine Plasma Fibrinolytic System | Q54195061 |
| | Fibrinogen as a risk factor for stroke and myocardial infarction | Q71438059 |
| | Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study | Q72235431 |
| | The amino acid sequence in fibrin responsible for high affinity thrombin binding | Q73769028 |
| | Interactions of human fibrinogens with factor XIII: roles of calcium and the gamma' peptide | Q73829141 |
| | Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system | Q73903671 |
| | A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis | Q77095008 |
| | Antithrombin I. Inhibition of thrombin generation in plasma by fibrin formation | Q78830644 |
| | Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors | Q79690468 |
| | Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence | Q79786324 |
| | gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation | Q79804224 |
| | Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex | Q80137272 |
| | Fibrinogen gamma' in ischemic stroke: a case-control study | Q80604991 |
| | γ'/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke | Q82770771 |
| | Association between γ' fibrinogen levels and inflammation | Q82973011 |
| | Fibrinogen γ' levels in patients with intracerebral hemorrhage | Q84943376 |
| | Elevated fibrinogen gamma' ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome | Q84990539 |
| | Evidence that fibrinogen γ' regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans | Q86167016 |
| P433 | issue | 5 | |
| P921 | main subject | thrombosis | Q261327 |
| P304 | page(s) | 680-689 | |
| P577 | publication date | 2014-05-01 | |
| P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
| P1476 | title | The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice | |
| P478 | volume | 12 | |